What Is the Fair Value of UnitedHealth Group (UNH) Stock? Intrinsic Value Analysis
Quick Answer
As of July 2026, UnitedHealth Group (UNH) is fairly valued to slightly undervalued, depending on the valuation model applied. Following a robust second-quarter earnings report that saw the company raise its full-year 2026 guidance, the stock is trading around $424 per share.
Our blended intrinsic value analysis—incorporating Discounted Cash Flow (DCF), P/E multiples, PEG ratios, EV/EBITDA, and the Dividend Discount Model (DDM)—suggests a fair value range between $395 and $475 per share. While conservative earnings-based DCF models suggest the stock is fully priced, free cash flow models and forward-looking multiple analyses indicate upside potential. Notably, Morningstar recently upgraded its fair value estimate for UNH to $475 UnitedHealth Earnings: Strength Across the Board Boosts 2026 Outlook | Morningstar, reflecting strong margin expansion and exceptional cash generation.
Current Stock Price & Valuation
UnitedHealth Group continues to dominate the healthcare sector. In mid-July 2026, UNH reported Q2 revenue of $112 billion, beating consensus estimates, alongside a massive 56% adjusted EPS growth to $6.38 UnitedHealth Earnings: Strength Across the Board Boosts 2026 Outlook | Morningstar.
Here is a snapshot of UNH's market positioning as of late July 2026:
- Current Stock Price: ~$424.62 UNH DCF Analysis: Intrinsic Value $324 vs Price $425
- Market Capitalization: ~$380 billion UnitedHealth Group (UNH) Fair Value Analysis (2026)
- Trailing P/E Ratio: 26.7x UnitedHealth Group (UNH) Fair Value Analysis (2026)
- Forward P/E Ratio: 19.5x UnitedHealth Group (UNH) Fair Value Analysis (2026)
- 2026 EPS Guidance: $19.50 - $20.00 UnitedHealth Earnings: Strength Across the Board Boosts 2026 Outlook | Morningstar
The market reacted positively to the Q2 2026 earnings, sending shares up roughly 5% as the company demonstrated excellent cost control, highlighted by a medical cost ratio (MCR) decline to 86.7% from 89.4% a year prior UnitedHealth Earnings: Strength Across the Board Boosts 2026 Outlook | Morningstar.
Detailed Analysis
To determine the true intrinsic value of UNH, we must look beyond the headline price and apply five distinct valuation methodologies.
1. Discounted Cash Flow (DCF) Analysis
DCF analysis values a company based on the present value of its future cash flows. We can look at this through two lenses: Earnings and Free Cash Flow (FCF).
Earnings-Based DCF:
- Current EPS (TTM): $16.34 UNH DCF Analysis: Intrinsic Value $324 vs Price $421
- 10-Year Growth Rate: 13.2% UNH DCF Analysis: Intrinsic Value $324 vs Price $421
- Discount Rate: 11% UNH DCF Analysis: Intrinsic Value $324 vs Price $421
- Terminal Growth Rate: 4% UNH DCF Analysis: Intrinsic Value $324 vs Price $421
- Result: This strict earnings model yields an intrinsic value of $323.72, suggesting the stock is overvalued UNH DCF Analysis: Intrinsic Value $324 vs Price $421.
Free Cash Flow (FCF) DCF: Because UNH is a cash-generating machine, FCF often paints a more accurate picture. Using a base FCF of ~$18.5 billion to $26.5 billion, an 8% growth rate, a 9% discount rate, and a 3.5% terminal rate, the FCF-based intrinsic value lands at $446.00 per share UnitedHealth Group (UNH) Fair Value Analysis (2026). This implies the stock is slightly undervalued at current levels.
2. P/E Multiple Analysis
Historically, UNH has commanded a premium valuation due to its wide economic moat and predictable growth.
- Forward EPS: $19.75 (midpoint of 2026 guidance) UnitedHealth Earnings: Strength Across the Board Boosts 2026 Outlook | Morningstar
- Historical Average P/E: ~22x
- Calculation: $19.75 × 22 = $434.50 Based on historical earnings multiples, UNH is currently trading at a slight discount to its fair value of $434.50.
3. PEG Ratio Analysis
The Price/Earnings-to-Growth (PEG) ratio helps contextualize the P/E ratio against the company's growth rate.
- Forward P/E: 19.5x UnitedHealth Group (UNH) Fair Value Analysis (2026)
- Expected Long-Term Growth Rate: 13.2% UNH DCF Analysis: Intrinsic Value $324 vs Price $421
- Calculation: 19.5 / 13.2 = 1.47 A PEG ratio under 1.5 is generally considered attractive for a blue-chip, wide-moat company like UnitedHealth. This indicates the stock is fairly valued relative to its double-digit growth trajectory.
4. EV/EBITDA Valuation
Enterprise Value to EBITDA is crucial for assessing UNH without the distortion of capital structure.
- Current EV/EBITDA (TTM): ~12.5x UnitedHealth Group (UNH) Fair Value Analysis (2026)
- EBITDA: ~$28.9 billion UNH Fair Value: UnitedHealth Group Inc. | MarketFairValue At 12.5x EV/EBITDA, UNH is trading in line with its large-cap healthcare peers. If the market rewards UNH's recent margin expansion with a historical 14x multiple, the implied fair value pushes closer to $460 per share.
5. Dividend Discount Model (DDM)
For income-focused investors, the DDM values the stock based on future dividend payouts.
- Annual Dividend: $9.28 UNH Fair Value: UnitedHealth Group Inc. | MarketFairValue
- Dividend Growth Rate: 6.4% UNH Fair Value: UnitedHealth Group Inc. | MarketFairValue
- Required Rate of Return: 8.5%
- Calculation: $9.28 / (0.085 - 0.064) = $441.90 The DDM suggests a fair value of roughly $442, reinforcing the narrative that the stock is slightly undervalued.
Bull Case
The bullish argument for UNH in July 2026 centers on its exceptional operational efficiency. In Q2 2026, the company drove its medical cost ratio down to 86.7%, a significant improvement from 89.4% in the prior year UnitedHealth Earnings: Strength Across the Board Boosts 2026 Outlook | Morningstar. This margin expansion allowed management to raise 2026 operating cash flow guidance to a staggering $24 billion and increase share repurchases to at least $5 billion UnitedHealth Earnings: Strength Across the Board Boosts 2026 Outlook | Morningstar. Analysts at Morningstar raised their fair value estimate by 11% to $475 per share, citing these robust cash flows UnitedHealth Earnings: Strength Across the Board Boosts 2026 Outlook | Morningstar.
Bear Case
The bearish perspective relies heavily on conservative earnings-based DCF models. If we apply a strict 11% discount rate to UNH's EPS growth, the intrinsic value drops to $323.72, implying a -30% margin of safety UNH DCF Analysis: Intrinsic Value $324 vs Price $421. Furthermore, UNH operates in a highly regulated environment. Any unexpected shifts in Medicare Advantage reimbursement rates or broader healthcare policy could compress margins and slow the 13.2% projected long-term growth rate.
Key Metrics Summary
| Metric | July 2026 Value | Implication |
|---|---|---|
| Stock Price | $424.62 | Baseline |
| Forward P/E | 19.5x | Modest premium, but below historical highs |
| PEG Ratio | 1.47 | Fairly valued relative to growth |
| Dividend Yield | ~2.1% | Reliable income generation |
| 2026 EPS Guidance | $19.50 - $20.00 | Strong upward revision |
| Morningstar Fair Value | $475.00 | Undervalued |
| FCF DCF Fair Value | $446.00 | Undervalued |
Frequently Asked Questions
Is UNH stock a buy, sell, or hold in July 2026?
Based on the convergence of multiple valuation models, UNH is a strong hold for current investors and a cautious buy for long-term investors. The stock is trading slightly below its blended fair value of ~$440, offering a modest margin of safety alongside reliable dividend growth.
Why did UNH stock rise in July 2026?
UNH shares rose approximately 5% in mid-July 2026 following a stellar Q2 earnings report. The company reported $112 billion in revenue, posted 56% adjusted EPS growth, and raised its full-year 2026 EPS guidance to $19.50-$20.00 UnitedHealth Earnings: Strength Across the Board Boosts 2026 Outlook | Morningstar.
What is UNH's dividend yield and is it safe?
UNH currently offers a dividend yield of approximately 2.1%, paying out $9.28 annually per share UnitedHealth Group (UNH) Fair Value Analysis (2026). Given the company's projected $24 billion in operating cash flow for 2026 UnitedHealth Earnings: Strength Across the Board Boosts 2026 Outlook | Morningstar, the dividend is exceptionally safe and has ample room for continued high-single-digit annual growth.
How does UNH's medical cost ratio (MCR) impact its valuation?
The MCR measures the percentage of premium revenues spent on clinical services. A lower MCR means higher profitability. In Q2 2026, UNH reduced its MCR to 86.7% from 89.4% UnitedHealth Earnings: Strength Across the Board Boosts 2026 Outlook | Morningstar. This 270-basis-point improvement directly translates to billions in free cash flow, which is why cash-flow-based valuation models have recently adjusted upward.
Final Verdict
After running UnitedHealth Group through five distinct valuation methodologies, the data points to a clear conclusion: UNH is fairly valued to slightly undervalued.
While a strict, high-discount-rate earnings DCF model suggests the stock is overpriced at $424, this model ignores the reality of UNH's massive free cash flow generation. When we look at the Free Cash Flow DCF ($446), the Dividend Discount Model ($442), and historical P/E multiples ($434), a consensus fair value emerges in the $440 to $450 range.
With management raising 2026 guidance and executing brilliantly on cost controls, UNH remains a premier, wide-moat compounder. Investors buying at current levels are paying a fair price for one of the highest-quality businesses in the global healthcare sector.
Ready to Analyze Your Next Investment?
Get a free AI-powered fair value analysis on any stock. See intrinsic value, margin of safety, and institutional-grade risk metrics in seconds. No credit card required.
Want full access to our institutional research tools? Explore Invest Daily Pro.
You're reading about dividend safety. But is YOUR dividend actually safe?
Our AI analyzes payout ratio trends, free cash flow coverage, balance sheet risk, and dividend growth history to give every stock a Fortress Score from 0–100.
Watch: Related Videos
from Invest DailyGet This Analysis in Your Inbox Every Morning
Get our daily market briefing with institutional-grade analysis, key developments, and actionable strategy - delivered before the opening bell.
Essential Reading: Top Investor Guides
Our most comprehensive guides - start here to build a complete investing foundation.
Market Basics
Stock Market Fundamentals: How Markets Work, Reading Charts, and Technical Analysis
Portfolio Strategy
Portfolio Management Masterclass: Asset Allocation, Diversification, and Rebalancing
Retirement
The Complete Retirement Planning Guide: 401(k), IRA, Roth, and FIRE Strategy
Dividend Income
The Ultimate Guide to Dividend Investing: How to Build a Safe Income Portfolio
Valuation
The Complete Guide to Stock Valuation: How to Calculate Intrinsic Value
Financial Statements
How to Read a Balance Sheet Like a Professional Analyst
Monetary Policy
Understanding the Federal Reserve: How Monetary Policy Actually Works
Real Estate
Real Estate Investment Trusts (REITs): A Complete Investor's Guide
Options & Hedging
Options Basics: How to Use Derivatives to Protect Your Portfolio
Investor Psychology


